Acute inflammatory processes are characterized by an accumulation of PMN 111 , which release a series of enzymes by extrusion of their granules during phagocytosis or cell disintegration 121 . Besides acid hydrolases, mainly neutral serine proteinases such as leukocyte elastase and cathepsin G as well as the metallo proteinase collagenase [31 are released. Furthermore, toxic oxygen radicals are produced in connection with the respiratory burst of the cells 141 . The extracellularly released enzyme activity in the serum is controlled by plasma proteinase inhibitors like a r PI isl and a 2 -macroglobulin l61 . In addition, inhibitors of neutral proteinases were found in the cytosol of leukocytes and macrophages in man 17 The relevance of inhibitors, found in the cytosol of leukocytes, is still under discussion. Protection of cytoplasmic proteins against proteinases released from the granules during phagocytosis seems to be a major function 19 ' 12, 151 . Cytosol inhibitors may also be responsible for the blocking of enzymes when cell degradation takes place during inflammation 1121 , while the concentration of plasma inhibitors is possibly not efficient in tissue for the control of proteinase activity 111 .
This report describes the purification and biochemical characterization of a cytosolic neutral serine proteinase inhibitor from bovine PMN.
Materials and Methods

Chemicals
The 
Protein determination
Protein was determined with the Ninhydrin reagent^ 16 1 using bovine serum albumin as standard.
Gel electrophoresis
Sodium dodecyl sulphate-polyacrylamide gel electro phoresis (SDS-PAGE) in 10% gels was carried out by the method of Laemmlit 173 under nonreducing condi tions. The samples were applied in 0.5^g to 2.0-Mg aliquots in a volume of 20 μι, respectively. Proteins were stained with Coomassie Brillant Blue R 250 (Serva, D-6900 Heidelberg).
Isoelectric focusing (IEF) was performed with 5% Polyacrylamide gels containing 2.4% carrier ampholytes in the pH range of 3.5 to 9.5 according to Görg et al.l 18 !.
Protein samples were applied in 20-ßg to 60-ßg aliquots in a volume of 20 μ/, respectively. Coomassie Brillant Blue R250 was used for protein staining. Prior to stain ing the pH-gradient was determined with a pH surface electrode.
Western blot in connection with staining by 125 
1-labeled leukocyte elastase
Iodination of human leukocyte elastase was performed according to Greenwood and Hunter^1 9 !. Subsequent to the radiolabeling of the enzyme non-radioactive iodide was added to the mixture to give a total concen tration of 0.35% (w/v). Unbound iodine was separated from 125 I-elastase by the use of a Sephadex G-25 col umn which was run with 0.1 mol// Tris, 0.5 mol// NaCl, 1 % ovalbumin (w/v), adjusted to pH 7.5 with HCl.
The procedure used for Western blot has been described by Towbin 
Separation of bovine leukocytes
Bovine leukocytes (1.6 χ 10 8 cells/m/) were separated using a discontinuous gradient of Percoll according to Hjorth et alJ 22 J. The interphase, containing lympho cytes as well as monocytes, and the phase between the two Percoll solutions, containing PMN, were removed and washed twice with PO^e/NaCl. Both cell fractions were adjusted to an amount of 5 χ 10 7 cells/m/. Dif ferent cell types were identified using Giemsas and May-Grünwald's staining solutions according to PappenheW 23 J.
Purification of the PMN-I
Leukocytes (1 χ 10 8 cells/m/) transfered to PO^/NaCl containing 8% saccharose were homogenized by nitrogen cavitation (20 atü, 13.5 min)l 24 l. The cytosol was separated from the membranous particles by ultracentrifugation for 60 min at 220000 xg. Subsequently, protein was precipitated by the addition of 2 mol// ammonium sulfate to the supernatant, i.e. the cytosol. After 1 h of stirring at 2 °C the precipitate was separated by centrifugation at 4000 χ g for 45 min. The super natant containing the inhibitor activity was dialysed against 50 mmol// Tris/phosphate, pH 7.5, and con centrated by ultrafiltration with negative pressure using a Visking dialysis tube to a concentration of 40 mg to 45 mg protein/m/. Two ml of the sample was applied to a prepacked FPLC-anion exchange chromatography column (Mono Q HR 10/10, Pharmacia). The elution was performed at 20 C by a linear concentration gra dient ranging from 0.02 mol// to 0.56 mol// Tris/phos phate, pH 7.5, with a flow rate of 0.5 m//min using a chromatography unit of LKB. Five-m/ fractions were collected at 4 °C and aliquots of each fraction were tested for inhibitory activity against leukocyte elastase. Fractions with inhibitory activity were pooled, concen trated by ultrafiltration and dialysed against 0.1 mol// phosphate, 0.1 mol// NaCl, pH 6.8. The dialysed ma terial (10-30 mg protein) was applied in 2 ml to a calibrated preparative HPLC-gel permeation chromatog raphy column (Ultro Pac TSK G 2000, LKB) for further purification. The calibration of the column was obtained with marker proteins as indicated ( Fig. 2 ) ac cording to Laurent and Killanderl 25 !. Protein was eluted with 0.1 mol//phosphate, 0.1 mol//NaCl, pH 6.8, and the flow rate was 0.5 m//min. Five-m/ fractions were collected, analysed by SDS-PAGE (not shown) and tested for inhibitory activity against leukocyte elastase.
Reduction of the PMN-I fractions with mercaptoethanol
The PMN-I samples (each 0.6 mg protein in 3.8 ml 0.5 mol// Tris/HCl pH 8.1) were reduced by the addition of mercaptoethanol to a final concentration of 0.1 mol//. After incubation of the reaction mixtures for 60 min at 20 C iodoacetamide was added to a final concen tration of 0.1 mol// and the mixtures were incubated further 60 min at 2 °C. The samples were dialysed over night against PO| e /NaCl and analysed for their inhibi tory activity against leukocyte elastase and by SDS-PAGE.
Activity and inhibition measurements
The enzyme assays were performed in a final volume of 1 ml and at a temperature of 25 °C. The velocity of reac tion of the enzymes with the substrates (A/i^s/min) was determined using the Eppendorf calculator (CKΕ 6455) for the first 2 min subsequent to the addition of substrate. For the determinations of the type of inhibi tion, the serine proteinases were first incubated with PMN-I for 5 min at 25 °C before adding the appropriate substrate. Inhibition was studied using the methods of Lineweaver and Burkl 26 ! and Henderson^2 7 !. The as sociation rate constant k on was measured and calculated according to Biethl 28 !.
Human leukocyte elastase was assayed according to Wenzel et al.l 29 ! using a buffer system of 0.1 mol// Hepes, 2 mol// NaCl and 0.05% Triton X-100 (v/v) adjusted to pH 8.0 with ammonia. The photometrical determination of the type of inhibition was accomplished with 3.9 nmol// enzyme and PMN-I in a range of The enzymes as well as the PMN-I sample used in the assays were previously active site titrated, i.e. the per centages of active molecules were determined using corresponding substrates and inhibitors respectively. First of all trypsin was titrated with the covalently binding substrate 4-nitrophenyl guanidinobenzoate by the method of Shaw et al. as described in refJ 35 !. The inhibitor aprotinin, required for the standardiza tion of chymotrypsin, was assayed by the reaction with titrated trypsin and found to be 100% active. Both the inhibitor and the enzyme were standardized by the above-mentioned photometrical enzyme assays. Subsequently, chymotrypsin was taken for the titration of human -PI. This inhibitor was used for the titra tion of leukocyte as well as pancreatic elastase using the corresponding photometrical enzyme assays. PMN-I was active site titrated by the already titrated serine pro teinases using again the corresponding photometrical enzyme assays. The percentage of active molecules was calculated from the complex-forming enzyme-and in hibitor-molecules, respectively, in relation to the total concentration of the corresponding molecules in the assay.
Immunological analysis in agarose gels
For the preparation of antisera rabbits were immunized with c^-PI and PMN-I according to Mossmann et alJ 38 J with an amount of 750 μ% antigen per animal. In the latter case PMN-I was first bound to chymotrypsin, which was immobilized on Eupergit Ö 31 \ assuming that the complex would be of higher antigenicity than the isolated inhibitor. Both antisera were tested for their reaction with o^-PI and PMN-I according to Ouchterlony* 39 !.
Results and Discussion
Comparison of the inhibitory activity of PMN and lymphocytes-monocytes
The leukocytes, separated by discontinuous Percoll gradients, were homogenized and tested for their inhibitory activity in the leukocyte elastase assay. In contrast to the PMN-fraction only a low specific inhibitory activity was found in the lymphocyte-monocyte fraction. The latter fraction was contaminated by 13% PMN. Therefore, it could be calculated that the inhibitory activity of the lymphocyte-monocyte fraction was due to the residual PMN (Table 1) . This result gives evidence for the bovine inhibitor of neutral proteinases being a PMN-specific protein. 
Preparation of PMS-chymotrypsin
PMS-chymotrypsin was prepared according to the method of Ako et alJ 36 l. In detail, 500 mg chymotrypsin in 50 ml 0.1 mol// Tris buffer, pH 8.0, containing 0.1 mol// NaCl, 0.12 mol// CaCl 2 and 13% methanol were titrated with 0.04 mol// PMSF (dissolved in acetone) by adding 0.1-m/ aliquots at five-minute intervals until no enzymatic activity could be determined in the photometrical assay. The PMS-chymotrypsin preparation was dialysed overnight against 1 mol// potassium phosphate pH 7.0 and in order to test the binding of PMN-I to PMS-chymotrypsin, the latter was first immobilized on Eupergit Ö 31 h
Purification of PMN-I
The following purification procedure was established:
(i) ammonium sulphate precipitation, (ii) anion exchange chromatography (Fig. 1) and, (iii) gel permeation chromatography (Fig. 2) .
The result of a typical purification procedure is summarized in Table 2 showing a 60-fold concentration of the PMN-I and a yield of 2.3%. In gel permeation chromatography two Table 2 . Purification of the bovine PMN-inhibitor from leukocytes.
The data represent one preparation as an example of the purification procedure.
Step Inhibition of leukocyte elastase. Table 3 . Effect of the reduction by mercaptoethanol on the specific inhibitory activity of the PMN-I fractions a and b. peaks -(a) and (b) -with a molecular mass of 73 kDa and 36.5 kDa, respectively, were obtained which differed in their specific inhibitory activity (Table 3) . Whereas PMN-I fraction (a) appears to contain a minor contamination, the single band obtained with fraction (b) indicate the purity of this preparation (Fig. 3) .
The PMN-I fractions were stored frozen at -80 °C. At this temperature the PMN-I is stable for 5 to 6 months. 
Chemical and physical characteristics
The molecular mass of the monomeric PMN-I could be determined as 36.5 kDa using a cali brated HPLC column (Fig. 2) has a molecular mass of 50 kDa and is therefore not identical with the PMN-I described in the paper.
On IEF, PMN-I fraction (b) showed five protein bands with isoelectric points of 5.0, 5.5, 5.7, 5.9 and 6.3, whereas fraction (a) displayed only the band of pi 5.0 (Fig. 4, A) . The bands of pi 5.0, 5.5, 5.7 and 5.9 formed complexes with 125 1-labeled leukocyte elastase (Fig. 4, B) , whereas the band of pi 6.3 did not bind the radiolabeled enzyme.
As shown in Table 3 , treatment of PMN-I frac tion (a) with mercaptoethanol followed by alkylation increased the specific inhibitory activity (IU/mg protein) from 25% to 62% of that of fraction (b). The activity of the latter was only marginally increased. When, however, the sam- pies were applied to SDS-PAGE the reduced fraction (a) migrated at the same rate as fraction (b) which in turn did not differ from the nonreduced fractions (Fig. 3) .
The behaviour of PMN-I fraction (a) on reduc tion by mercaptoethanol and its molecular mass suggest that this material is a dimer of PMN-I contained in fraction (b). In the following studies, only the properties of PMN-I monomer (fraction b) were further investigated and the name PMN-I was used for this preparation.
Inhibitory properties
A prerequisite for the calculation of the kinetic data is the determination of the proportion of active molecules of the enzyme or the inhibitor solutions. Therefore, active-site titrations were performed. The percentages of catalytically active enzyme molecules were in a range of 40% to 70% for the tested serine proteinases, whereas in the two inhibitor solutions -c^-PI and PMN-I -10% of the molecules were active.
The reciprocal plotting of the kinetic data ap parently demonstrate that the interaction of PMN-I with serine proteinases is a non-com petitive one (Fig. 5) . But, if the inhibitor is tightly bound to the enzyme a competitive inhibition mechanisms is virtually indistinguish able from a non-competitive mechanism under these circumstances as shown by Henderson 1271 . Thus a clear definition on the inhibition mecha nism cannot be given. However, the fact that PMN-I does not bind to PMS-chymotrypsin may indicate that the reactive OH-group of the serine residue in the active site of the enzyme is involved in the reaction mechanism of inhibitor and serine proteinase (Table 4) The specific inhibitory activity was tested with human leukocyte elastase. 
Immunological properlies
In the immunodiffusion assay according to Ouchterlony, the rabbit antiserum raised to of!-PI showed no cross reaction with PMN-I and vice versa (Fig. 7) . This immunological discrepancy indicates the different origin of both inhibitors.
The physiological relevance of PMN-I may be restricted to the protection of the cell from its own proteinases 112J , but could also be rele vant for the protection of tissue in infectious diseases because of the inadequate concen tration of serum inhibitors* l] . Probably, they are also involved in the regulation of tumor growth i44i . However, further investigations have to clarify the precise role of PMN-I in physiolo gical and pathological events as discussed in the accompanying paper.
